GB Sciences Inc

General ticker "GBLX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $1.4M

GB Sciences Inc does not follow the US Stock Market performance with the rate: -12.7%.

Estimated limits based on current volatility of 13.9%: low 0.00$, high 0.00$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

  • 2024-03-31 to 2025-03-31 estimated range: [0.00$, 0.01$]
  • 2025-03-31 to 2026-03-31 estimated range: [0.01$, 0.02$]

Financial Metrics affecting the GBLX estimates:

  • Negative: Non-GAAP EPS, $ of 0 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -28.10 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: Industry operating cash flow per share per price (median), % of -11.04 <= 3.85

Similar symbols

Short-term GBLX quotes

Long-term GBLX plot with estimates

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $1.87MM $1.67MM $1.42MM
Operating Income $-1.87MM $-1.67MM $-1.42MM
Non-Operating Income $1.72MM $-2.45MM $0.06MM
Interest Expense $0.47MM $0.18MM $0.22MM
R&D Expense $0.00MM $0.00MM $0.26MM
Income(Loss) $-0.15MM $-4.13MM $-1.36MM
Taxes $-1.80MM $2,631,565.00MM $0.00MM
Profit(Loss) $1.66MM $-2,631,569.13MM $-1.36MM
Stockholders Equity $-1.78MM $-4.41MM $-5.31MM
Assets $2.55MM $0.35MM $0.10MM
Operating Cash Flow $-1.87MM $-1.53MM $-0.98MM
Capital expenditure $0.20MM $0.03MM $0.00MM
Investing Cash Flow $1.45MM $-0.03MM $0.32MM
Financing Cash Flow $-0.50MM $1.43MM $0.56MM
Earnings Per Share* $0.01 $-7,356.48 $-0.00

* EPS are Split Adjusted, recent splits may be reflected with a delay.